BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17431401)

  • 1. Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction.
    Fujimoto T; Anderson K; Jacobsen SE; Nishikawa SI; Nerlov C
    EMBO J; 2007 May; 26(9):2361-70. PubMed ID: 17431401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function.
    Tokita K; Maki K; Mitani K
    Cancer Sci; 2007 Nov; 98(11):1752-7. PubMed ID: 17894555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.
    Zjablovskaja P; Kardosova M; Danek P; Angelisova P; Benoukraf T; Wurm AA; Kalina T; Sian S; Balastik M; Delwel R; Brdicka T; Tenen DG; Behre G; Fiore F; Malissen B; Horejsi V; Alberich-Jorda M
    Cell Death Differ; 2017 Apr; 24(4):705-716. PubMed ID: 28186500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
    Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
    J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumoylation of CCAAT/enhancer-binding protein α is implicated in hematopoietic stem/progenitor cell development through regulating runx1 in zebrafish.
    Yuan H; Zhang T; Liu X; Deng M; Zhang W; Wen Z; Chen S; Chen Z; de The H; Zhou J; Zhu J
    Sci Rep; 2015 Mar; 5():9011. PubMed ID: 25757417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
    Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1.
    Feng J; Iwama A; Satake M; Kohu K
    Br J Haematol; 2009 May; 145(3):412-23. PubMed ID: 19298589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
    Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
    PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.
    Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B
    Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.
    Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
    Mol Cell Biol; 2006 Apr; 26(7):2570-82. PubMed ID: 16537903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C/EBPα in normal and malignant myelopoiesis.
    Friedman AD
    Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages.
    Iwasaki H; Mizuno S; Arinobu Y; Ozawa H; Mori Y; Shigematsu H; Takatsu K; Tenen DG; Akashi K
    Genes Dev; 2006 Nov; 20(21):3010-21. PubMed ID: 17079688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.
    Guo H; Ma O; Speck NA; Friedman AD
    Blood; 2012 May; 119(19):4408-18. PubMed ID: 22451420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulation.
    Willcockson MA; Taylor SJ; Ghosh S; Healton SE; Wheat JC; Wilson TJ; Steidl U; Skoultchi AI
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17841-17847. PubMed ID: 31431533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitment.
    Rangatia J; Vangala RK; Treiber N; Zhang P; Radomska H; Tenen DG; Hiddemann W; Behre G
    Mol Cell Biol; 2002 Dec; 22(24):8681-94. PubMed ID: 12446786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Runx1, c-Myb, and C/EBPalpha couple differentiation to proliferation or growth arrest during hematopoiesis.
    Friedman AD
    J Cell Biochem; 2002; 86(4):624-9. PubMed ID: 12210729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc is a critical target for c/EBPalpha in granulopoiesis.
    Johansen LM; Iwama A; Lodie TA; Sasaki K; Felsher DW; Golub TR; Tenen DG
    Mol Cell Biol; 2001 Jun; 21(11):3789-806. PubMed ID: 11340171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interaction of transcriptional coactivator ASC-2 and C/EBPalpha in granulocyte differentiation of HL-60 promyelocytic cell.
    Hong S; Lee MY; Cheong J
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1257-62. PubMed ID: 11302752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia.
    Jena N; Sheng J; Hu JK; Li W; Zhou W; Lee G; Tsichlis N; Pathak A; Brown N; Deshpande A; Luo C; Hu GF; Hinds PW; Van Etten RA; Hu MG
    Leukemia; 2016 May; 30(5):1033-43. PubMed ID: 26707936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.